Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Dyspepsia Companies

There weren't specific companies exclusively focused on dyspepsia. Dyspepsia, often referred to as indigestion, is a common symptom rather than a specific medical condition. It can be caused by various underlying factors such as gastrointestinal disorders, lifestyle choices, or other medical conditions.

Dyspepsia Key Companies Latest Dyspepsia Companies Update

January 2023: A licensing agreement has been announced by MetaMe Health, a manufacturer of prescription digital therapeutics (PDT), for a novel gut-directed hypnotherapy program designed to treat functional dyspepsia. The agreement could potentially provide the company, which is presently engaged in the development of pharmaceuticals for gastrointestinal disorders, with access to a significant market. Even during or after meals, functional dyspepsia is a chronic disorder of the upper gastrointestinal tract characterized by abdominal pain, indigestion, nausea, and a feeling of fullness or bloating. It is diagnosed when there is no other obvious cause for the patient's symptoms. Although the digestive disorder is estimated to affect one in ten individuals, MetaMe Health asserts that functional dyspepsia is difficult to treat due to the lack of consistently effective medications.

May 2022: The US Food and Drug Administration (FDA) approved MounjaroTM (tirzepatide) injection, a once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed by Eli Lilly and Company. The drug was approved in May 2022 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Mounjaro is not recommended for patients with type 1 diabetes mellitus and has not been studied in individuals with a history of pancreatitis. Mounjaro, the first and only GLP-1 receptor agonist to receive FDA approval, functions as an endogenous incretin hormone receptor activator via a single molecule. Throughout the SURPASS program, which was designed to evaluate the efficacy and safety of Mounjaro in a diverse group of individuals with type 2 diabetes who may be treated in clinical practice, it outperformed all comparators in terms of A1C reductions.List of Dyspepsia Key companies in the market

AstraZeneca

GlaxoSmithKline

Takeda Pharmaceutical Company

Johnson & Johnson

Eisai Co., Ltd

Abbott Laboratories

Salix Pharmaceuticals

Bayer AG

Boehringer Ingelheim GmbH

Sanofi

Allergan Plc

Dyspepsia Market Highlights:

Dyspepsia Market Size

Dyspepsia Market Trends

Dyspepsia Market Analysis

Dyspepsia Market Share

Dyspepsia Market Highlights:

Dyspepsia Market Trends

Dyspepsia Market Analysis

Dyspepsia Market Share

Dyspepsia Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.